Pharmaceutical market in Romania 2008

"The Romanian pharmaceutical market has experienced intensive growth in recent years. 2007 and 2008 have seen a lower increase rate, but we believe there still exist a lot of market niches to fill. Per capita drug consumption is also still much lower in comparison with Western markets. That is why it is worth to invest there, as it would require relatively less effort than in more saturated Western countries. Knowing from our customers that pharma companies show great interest in the Romanian market, we have decided to publish this report in order to show the main characteristics, forecasts, barriers and opportunities of this attractive market".

PMR MarketInsight Methodology

This report was prepared using PMRs MarketInsight Methodology. PMR MarketInsight is a methodology developed by PMR which assists in the complex preparation of industry reports. It defines the ways in which data should be collected for such reports and outlines the methods to be used in analysing the information collected in order to obtain a true picture of the market in question. It also contains special procedures to follow in the case of incomplete market.

PMR MarketInsight precisely defines report content and structure. Industry reports prepared using PMR MarketInsight are based on information from a variety of available statistical, industry (specialist press, the internet), general and official sources as well as information from PMR's own database and primary research carried out independently by PMR. The sources we use are individually tailored to each project. PMR MarketInsight is the result of over 10 years of experience in conducting industry analysis on Central and Eastern European markets.

Report description

Pharmaceutical market in Romania 2008 paints a comprehensive portrait of the Romanian pharmaceutical market and its path of growth and development during the period from 2002 to 2008.

Data, analysis, solid, detailed forecasts for the period 2008-2010, along with pharmacy and hospital outlet activities and complete market value data presented by segment combine to help readers achieve a working knowledge of all facets of this complicated market.

Fresh and reliable data is carefully followed up with expert analysis of the market's most influential factors, including: epidemiologist, demographics, and prevailing conditions in the Romanian health care and legal systems.

Pharmaceutical market in Romania 2008 also provides a comprehensive source of useful information concerning the market's major players, their market shares and financials, along with detailed profiles of the ten top performers. Information gleaned through in-depth interviews with market experts enhances the value of this timely document, as does its astute analysis of data and market trends with regard to wholesale and retail trends in distribution and sales and the distributors and pharmacy chains engaged in these pharmaceutical market activities.

Key sections

Section One presents an overview of the Romanian pharmaceutical market, including data describing trends and events of influence for the period 2002-2010, along with data on size and forecasts for the period 2008-2010 for the following market segments: Rx, retail and hospitals, domestically produced and imported drugs, original and generic drugs. Also provided is information on average prices for 2007 in the Rx, retail and hospital categories, as well as average drug prices by therapeutic category.

Section Two divides the Romanian pharmaceutical market into therapeutic categories and enumerates each categorys share in the total market as well as its development in the period 2005- 2007 along with forecasts for the period 2008-2010. Largest categories include drugs that treat: cardiovascular system, central nervous system, alimentary tract and metabolism, respiratory system, anti-infectives, musculo-skeletal system, genito-urinary system, antineoplastics and immunomodulating agents, blood and blood forming agents and other ATC groups.

Section Three focuses on Romanian pharmaceutical companies during 2002-2006, providing a comprehensive overview of activities, foreign trade and profiles of the countrys largest exporting entities. This section also features rankings of the 20 largest drug manufacturing firms for 2007 and H1 2008, as well as in-depth profiles of the ten largest market players.

Section Four provides data and analysis on the trends and influential factors guiding the development of the Romanian pharmaceutical market in 2002-2006, including demographic trends, epidemiological factors, influences of the healthcare and legal and regulatory systems and level of expenditures for pharmaceutical products.

Section Five centers its attention on the drug distribution segment, analysing key trends and events that have influenced development from 2002 to 2008 and forecasting the expected trends for 2008 to 2009. This section also profiles the wholesale and pharmacy distribution segments, and provides profiles and financial results for key market players.

The report also contains an Excel format directory of the 50 largest pharmaceutical companies currently active in the Romanian market, presented as a useful additional informational resource.

Report overview

Pharmaceutical market in Romania 2008 provides a comprehensive overview of the market segments, and analyses the effects of prevailing trends on the market as a whole as well as on the following segments, while forecasting trends for:

• Rx, retail and hospital market
• domestically produced and imported drugs 2002-2010
• original and generic drugs 2002-2010.

Given the complicated nature of the wide variety of products available on the pharmaceutical market, this report breaks them down by therapeutic category, exploring the largest groups in the years 2005- 2010 and defining their respective market shares. The groups include:

• cardiovascular system drugs
• central nervous system drugs
• drugs used to treat the alimentary tract and metabolic issues
• respiratory system drugs
• anti-infectives
• musculo-skeletal system drugs
• genito-urinary system drugs
• antineoplastics and immunomodulating agents
• blood and blood forming organs
• other ATC groups.

A study of the companies that manufacture, distribute and export pharmaceuticals in Romania is vital to a comprehensive understanding of the market and its activities. In addition to a general overview of top companies 2002-2006, the report offers details on:

• largest exporters, providing profiles of export activity
• rankings of top 20 companies - 2007 and H1 2008
• profiles of the ten largest companies.

Every market responds to trends, events and governmental activities that influence consumer habits and the conduct of business in general. Pharmaceutical market in Romania 2008 describes those demographic and epidemiological trends and health care and legal system conditions that affect the market, providing the latest information on:

• population, ageing and life expectancy trends
• mortality and morbidity factors
• prevalent trends affecting the health care system
• drug expenditures
• legislation and applicable institutions, EU legislation, and market authorisation
• patent protection, advertising and product pricing procedures.

Drug distribution in Romania is affected by various events and trends, and these are outlined in the report, along with anticipated conditions likely to prevail in 2008-2009. Profiles include:

• pharmaceutical wholesalers - segment profile and financial results and characteristics of key players
• pharmacy distribution - segment profile and financial results and characteristics of key players.

As a valuable enhancement, Pharmaceutical market in Romania 2008 features a directory of the 50 largest pharmaceutical companies active on the Romanian market.

The report functions as a useful tool for:

• companies currently active on the Romanian pharmaceutical market
• companies considering market entry into Romanian pharmaceuticals
• consulting and research companies and analytical institutes
• government agencies, embassies and other trade organizations.